The global positive airway pressure devices market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.06 billion in 2026 to USD 4.66 billion by 2034, registering a CAGR of 5.4% during the forecast period from 2026 to 2034. North America dominated the positive airway pressure devices market with a market share of 42.5% in 2025.
Positive airway pressure devices are medical devices that deliver pressurized air through a mask to keep the airway open and support breathing. Common types include continuous positive airway pressure (CPAP), automatic positive airway pressure (APAP), and bilevel positive airway pressure (BiPAP). These devices are widely used to manage sleep apnea and other breathing disorders.
Download a Free Sample To learn more about this report,
Growing Adoption of Connected and Personalized PAP Devices
The positive airway pressure devices market is increasingly shifting toward connected devices that combine therapy delivery with digital monitoring and personalized treatment support. Manufacturers are integrating AI, machine learning, cloud connectivity, and mobile applications to improve therapy comfort, adherence, and monitoring. These technologies allow clinicians and patients to access therapy information remotely and support more individualized sleep apnea management.
Expansion of Home-Based Sleep Therapy
Another important positive airway pressure devices market trend is the growing shift toward home-based diagnosis and treatment. Smaller, quieter, connected, and easier-to-use PAP devices are supporting treatment outside traditional clinical settings. Home-based care can improve convenience and access while enabling remote monitoring of therapy adherence and outcomes, particularly as healthcare systems increasingly emphasize decentralized respiratory and sleep care.
Rising Prevalence and Diagnosis of Sleep Apnea
The increasing diagnosis of obstructive sleep apnea is driving demand for positive airway pressure devices, particularly CPAP systems. PAP therapy remains a standard treatment option for obstructive sleep apnea, while greater awareness and access to sleep testing are encouraging more patients to seek treatment. The availability of home sleep testing and different PAP modalities is also improving access to therapy.
Challenges With Long-Term Patient Adherence
Patient adherence remains an important restraint for the positive airway pressure devices market because some users experience discomfort, mask-related problems, pressure intolerance, or difficulty adjusting to therapy. Inconsistent use can reduce treatment effectiveness and may discourage long-term device utilization. Manufacturers therefore need to improve comfort, usability, and individualized therapy settings to support sustained use.
Expansion of Remote Monitoring and Home-Based PAP Therapy
The growing use of home-based PAP initiation and remote monitoring is creating opportunities for device manufacturers to develop connected systems that support treatment outside traditional sleep laboratories. Cloud-based data can help clinicians monitor therapy usage and effectiveness, while telemedicine and digital applications can provide timely follow-up and patient support. These capabilities can improve convenience and expand access to sleep-disorder treatment.
Balancing Advanced Features With Affordability and Usability
Manufacturers face the challenge of incorporating connectivity, automated pressure adjustment, digital monitoring, and other advanced features while keeping devices comfortable, reliable, and affordable. More sophisticated systems can increase development and manufacturing complexity, while patients still require simple interfaces, effective masks, and convenient therapy. Regulatory requirements for connected and AI-enabled medical devices also add complexity to product development.
Continuous Positive Airway Pressure (CPAP) Devices Segment Dominated the Market with 54.6% Share in 2025
The continuous positive airway pressure (CPAP) devices segment dominated the positive airway pressure devices market with a 54.6% share in 2025, reaching USD 1.58 billion, and is projected to grow at a CAGR of 6.3% during 2026–2034. Automatic positive airway pressure (APAP) devices accounted for a 27.8% share, reaching USD 0.81 billion, and are projected to grow at a CAGR of 7.4%, while bilevel positive airway pressure (BiPAP) devices represented a 17.6% share, reaching USD 0.51 billion, with a CAGR of 6.9%.
CPAP devices remain widely adopted because they provide consistent airway pressure throughout sleep and are commonly used for obstructive sleep apnea treatment. APAP devices are gaining importance because they automatically adjust pressure according to changing breathing patterns. BiPAP devices also remain important for patients requiring different pressure levels during inhalation and exhalation.
Request Customizationto receive a tailored report.
COPD Segment is Projected to Grow at a CAGR of 7.2%
The COPD segment accounted for a 13.3% share of the positive airway pressure devices market in 2025, reaching USD 0.39 billion, and is projected to grow at a CAGR of 7.2% during 2026–2034. Obstructive sleep apnea dominated the market with a 68.2% share, reaching USD 1.98 billion, and is projected to grow at a CAGR of 6.7%, while respiratory failures accounted for an 18.5% share, reaching USD 0.54 billion, with a CAGR of 6.9%.
The growing use of positive airway pressure therapy in COPD management is supporting demand for specialized respiratory support. Obstructive sleep apnea remains the primary application because PAP therapy is widely used to maintain airway patency during sleep. Respiratory failure applications are also benefiting from the increasing use of non-invasive ventilation and improvements in respiratory care.
Home Care Segment Dominated the Market with 43.7% Share in 2025
The home care segment dominated the positive airway pressure devices market with a 43.7% share in 2025, reaching USD 1.27 billion, and is projected to grow at a CAGR of 7.6% during 2026–2034. Hospitals accounted for a 34.7% share, reaching USD 1.01 billion, and are projected to grow at a CAGR of 6.2%, while sleep laboratories represented a 21.6% share, reaching USD 0.63 billion, with a CAGR of 6.5%.
Home-based PAP therapy is becoming increasingly important because it provides greater convenience and allows patients to continue long-term treatment outside clinical settings. Hospitals remain important for diagnosis, initiation of therapy, and management of complex respiratory conditions. Sleep laboratories continue to support patient evaluation, titration, diagnosis, and monitoring of sleep-related breathing disorders.
Speak to an Analystto discuss market opportunities.
North America dominated the positive airway pressure devices market with a 42.5% share in 2025, reaching USD 1.23 billion, and is projected to grow at a CAGR of 6.4% during 2026–2034. The region's leading position is supported by the high prevalence and diagnosis of sleep apnea, established sleep-care infrastructure, and strong adoption of CPAP and other PAP therapies. Growing awareness of sleep-related breathing disorders and increasing use of connected home-based therapy are also supporting regional market growth.
The US market is supported by high awareness of sleep apnea, established sleep diagnostic facilities, and widespread adoption of CPAP and other positive airway pressure therapies. Increasing demand for home-based treatment, connected devices, and remote therapy monitoring is also contributing to market expansion.
Canada's market is supported by increasing awareness and diagnosis of sleep-related breathing disorders and growing demand for home-based PAP therapy. Improving access to sleep diagnostic services and increasing adoption of advanced respiratory devices are also supporting market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for a 27.3% share of the positive airway pressure devices market in 2025, reaching USD 0.79 billion, and is projected to grow at a CAGR of 6.1% during 2026–2034. Growth is supported by increasing diagnosis of sleep apnea, expanding sleep-care services, and growing adoption of advanced PAP devices. Rising healthcare expenditure and increasing awareness of the health consequences associated with untreated sleep disorders are also contributing to regional expansion.
The UK market is supported by increasing diagnosis and treatment of obstructive sleep apnea and growing demand for home-based PAP therapy. Expanding access to sleep services and increasing use of digitally connected respiratory devices are also supporting market growth.
Germany's market benefits from established healthcare infrastructure, increasing awareness of sleep-related breathing disorders, and growing adoption of PAP therapy. Demand for advanced and comfortable respiratory devices is supporting the expansion of positive airway pressure treatment.
Asia Pacific accounted for a 20.4% share of the positive airway pressure devices market in 2025, reaching USD 0.59 billion, and is projected to grow at the fastest CAGR of 8.2% during 2026–2034. Growth is supported by increasing healthcare expenditure, rising awareness of sleep apnea, improving diagnostic infrastructure, and growing adoption of home-based respiratory care. Expanding healthcare access and increasing availability of advanced PAP devices are also supporting regional market development.
Japan's market is supported by an aging population, established healthcare infrastructure, and increasing awareness of sleep-related breathing disorders. Growing demand for convenient home-based treatment and advanced PAP technologies is also contributing to market growth.
China's market benefits from a large patient population, increasing healthcare expenditure, and growing awareness of sleep apnea and respiratory disorders. Improvements in diagnostic infrastructure and increasing adoption of home-based PAP devices are supporting market expansion.
The Middle East and Africa accounted for a 4.0% share of the positive airway pressure devices market in 2025, reaching USD 0.12 billion, and is projected to grow at a CAGR of 6.5% during 2026–2034. Growth is supported by improving healthcare infrastructure, increasing awareness of sleep-related breathing disorders, and rising demand for respiratory care technologies. Expansion of specialized healthcare services and greater access to advanced medical devices are also supporting regional development.
The UAE market is supported by advanced healthcare infrastructure, increasing awareness of sleep disorders, and growing demand for modern respiratory treatment technologies. Expanding sleep-care services and increasing adoption of home-based PAP therapy are creating opportunities for market growth.
Africa's market is supported by improving healthcare infrastructure, increasing awareness of respiratory and sleep-related disorders, and expanding access to medical devices. Growing healthcare investments and gradual development of sleep diagnostic and treatment services are supporting the adoption of positive airway pressure devices.
The positive airway pressure devices market is competitive, with major companies focusing on CPAP, APAP, and BiPAP technologies, patient comfort, connected therapy, remote monitoring, and home-based respiratory care. ResMed Corporation, Royal Philips N.V., and Fisher & Paykel Healthcare Corporation Limited are among the prominent players, with companies investing in advanced PAP technologies and digital solutions to improve treatment effectiveness and patient adherence. ResMed, for example, offers connected PAP devices with digital health capabilities, while Fisher & Paykel Healthcare focuses on PAP devices, masks, and humidification technologies for sleep-disordered breathing.
ResMed Corporation
ResMed is a leading player in the positive airway pressure devices market, with a broad portfolio of CPAP, APAP, and bilevel devices supported by digital health technologies. The company focuses on improving patient comfort, therapy adherence, remote monitoring, and personalized treatment through connected PAP systems and digital platforms.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
N95 Masks Market Size, Share, Growth, Analysis, Report, 2034
Digital X-Ray Devices Market Size, Share, Growth, Analysis, 2034
Contrast Enhanced Ultrasound Market Size, Share, Growth, 2034
Active Wound Care Market Size, Share, Growth, Forecast, 2034
Perfusion System Market Size, Share, Growth, Forecast, 2034
Medical Digital Imaging System Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com